Home/Cessatech/Martin Juhl
MJ

Martin Juhl

Executive Management

Cessatech

Therapeutic Areas

Cessatech Pipeline

DrugIndicationPhase
CT001Acute pain management in children (aged 1-17)Phase 3 / Submitted for Approval